P.M.
Craig-McFeely, Prospective observational
cohort safety study to monitor the introduction of a non-CFC formulation of
salbutamol with HFA 134a in England.
International Journal of Clinical Pharmacology and Therapeutics, Vol 41 - No.
2/2003 (67-76)